WebPatients with Orbera experience 3.1x more weight loss than diet & exercise alone and are provided with the right tools and resources to successfully learn to keep it off. Meet the Orbera Gastric Balloon! If you are an existing Reshape patient and have questions regarding the patient portal, please contact Reshape at 1-844-937-7374. WebMar 5, 2024 · The FDA-approved ReShape Balloon TM involves a non-surgical weight loss procedure that uses advanced interconnected balloon technology designed to take up …
FDA reports five deaths related to weight-loss balloons - Pulse …
WebJun 6, 2024 · An additional five patients have died in association with intragastric balloons for the treatment of obesity, bringing the total number of deaths to 12 worldwide since 2016, said the US Food and Dr… WebMar 14, 2024 · The Orbera balloon had no cases of pancreatitis in the post-approval study; however, the Reshape duo had a 1.3% rate. Worldwide, 67% of reports were attributable to … tower hamlets food store
Intragastric Balloon Deaths: What the FDA Wants You to Know
WebAug 10, 2024 · Primary Care > Obesity FDA Warns of Gastric Balloon Deaths — 7 reports of death tied to obesity treatment since 2016. by Kristina Fiore, Deputy Managing Editor, MedPage Today August 10, 2024 WebThe ReShape IDB was FDA approved in 2015 for adults with BMI of 30–40 kg/m 2 with an obesity-related comorbidity. The ReShape IDB is inserted over a guide wire, and filled with a total of 750–900 mL of saline, depending on patient size. The balloon can be filled with a purpose-specific electric pump. WebMar 31, 2024 · SAN CLEMENTE, Calif., May 14, 2024 /PRNewswire/ -- ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial results for the three months ended March 31, 2024. Recent Highlights and Accomplishments. Achieved record revenues of $950 … powerapps health status